Unlock instant, AI-driven research and patent intelligence for your innovation.

Medicine for treating flap transplantation injury and application thereof

A transplant injury and drug technology, applied in the field of medicine, can solve the problems of amplifying inflammatory response, cell damage, aggravating organ damage and apoptosis, etc., to improve necrosis, improve treatment effect, and reduce oxidative damage.

Pending Publication Date: 2021-06-18
上海百晓生物科技有限公司
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Paradoxically, restoration of blood supply (i.e., reperfusion) leads to additional cellular damage and amplifies the inflammatory response through excess reactive oxygen and nitrogen, thereby exacerbating organ damage and apoptosis

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Medicine for treating flap transplantation injury and application thereof
  • Medicine for treating flap transplantation injury and application thereof
  • Medicine for treating flap transplantation injury and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0019] Grouping of Study Animals

[0020] The animals participating in this study were male Wistar rats aged 12-14 weeks, weighing 280-330 grams (g), a total of 60 were purchased from Slac Experimental Animals (Shanghai, China).

[0021] In the case of sufficient supply of standard laboratory food and tap water, put them in SPF room, light-dark cycle 12h, 18-25°C, relative humidity 40-70%, and establish I / R model for rats. Wistar rats were divided into six experimental groups with 10 rats in each group:

[0022] Sham-operated group: (1) The superficial abdominal wall arteries and veins at the pedicle were separated after the flap design was cut; (2) The flap was sutured in situ without ischemia-reperfusion treatment; (3) There was no special treatment after operation.

[0023] Remifentanil-H group: Remifentanil (10 μg / kg) was pretreated on the basis of the sham operation group.

[0024] Group I / R: The flap design and cutting method were the same as those in the sham operatio...

Embodiment 2

[0029] Aortic endothelial cell harvesting and cell culture

[0030] To study the effect of remifentanil at the cellular level, aortic endothelial cells were isolated from epigastric flaps of 20 Wistar rats aged 12-14 weeks and weighing 280-330 g.

[0031] All rats received an adequate supply of standard laboratory chow and tap water, and were housed in an SPF chamber with a 12-h light-dark cycle, 18-25°C, and 40-70% relative humidity.

[0032] Isolation of abdominal aortic endothelial cells: After anesthetized with pentobarbital sodium salt, cut the abdominal aorta according to the abdominal tangent, and perfuse the left ventricle with 1 mL of fetal bovine serum containing heparin (1000 U / mL); the aorta was obtained from a rat After taking it out, incubate in DMEM, add 20% fetal bovine serum containing heparin (1000U / mL); after the proximal end of the aorta is ligated, wash the ligated section with serum-free DMEM medium, and incubate the other side at 37°C with II Type colla...

Embodiment 3

[0034] cell treatment

[0035] The I / R injury model of aortic endothelial cells treated with hypoxia-reoxygenation was established, and the aortic endothelial cells were divided into the following groups:

[0036] Control group: cells were cultured at 37°C in DMEM medium containing 15% fetal bovine serum;

[0037] Hypoxia-reoxygenation group: cells were incubated at 37°C, 5% CO2, 3% O2, 92% N2 in DMEM medium for 12h, and then incubated at 37°C, 5% CO2, 95% O2 in serum-free DMEM medium 4h, hypoxia-reoxygenation treatment;

[0038] Hypoxia-reoxygenation + remifentanil group: before the hypoxia-reoxygenation treatment, the cells were treated with 0.1ng / mL remifentanil medium;

[0039] Hypoxia-reoxygenation + remifentanil + anisomycin (Anisomycin) group: before the hypoxia-reoxygenation treatment, the culture medium was treated with 1 ng / mL remifentanil and 10 ng / mL anisomycin.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a medicine for treating flap transplantation injury and application thereof, and belongs to the technical field of medicine, the main active ingredient of the medicine is remifentanil, the whole medicine is prepared from the remifentanil and one or more medicinal carrier excipients, the flap transplantation injury is ischemia reperfusion injury after flap transplantation, the medicine takes JNK as a target, and the flap transplantation injury comprises necrosis, inflammatory response or oxidative stress. By applying remifentanil to block JNK, oxidative damage, inflammatory infiltration and apoptosis caused by ischemia reperfusion after flap transplantation can be reduced, necrosis of transplanted flaps is effectively improved, and then the treatment effect of flap transplantation is improved.

Description

technical field [0001] The invention belongs to the technical field of medicine, and in particular relates to a medicine for treating skin flap transplantation injury and its application. Background technique [0002] Skin flap transplantation is one of the most common tissue transplantation techniques and is widely used in plastic surgery to repair defects caused by trauma, congenital diseases and tumor resection; although Flap surgery has been increasingly used in plastic and reconstructive surgery for many skin defects, and flap necrosis is still an important problem in flap transplantation, which seriously affects the therapeutic effect. In order to improve the prognosis of flap transplantation, it is necessary to improve the survival rate of flap. [0003] Ischemia causes tissue destruction due to dysfunction in oxygen delivery, accumulation of toxins, and depletion of cellular energy, leading to cellular necrosis. Paradoxically, restoration of blood supply (i.e., rep...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K31/4468A61P9/10A61P29/00A61P39/06
CPCA61K31/4468A61P9/10A61P29/00A61P39/06
Inventor 张琳琳
Owner 上海百晓生物科技有限公司
Features
  • R&D
  • Intellectual Property
  • Life Sciences
  • Materials
  • Tech Scout
Why Patsnap Eureka
  • Unparalleled Data Quality
  • Higher Quality Content
  • 60% Fewer Hallucinations
Social media
Patsnap Eureka Blog
Learn More